Pilot study of dogs with suppurative and non-suppurative Malassezia otitis: A case series

BMC Veterinary Research

Table 3 Clinical data of 5 cases diagnosed with Malassezia otitis with and without neutrophils

	Breed	Age (years)	Sex	Type of otitis	Duration of otitis	Previous treatments	Therapy at presentation
Case 1	Labrador Retriever	3.1	FS	Bilateral SMO	3 months	Topical Aurizon® Topical Osurnia® Topical acetylcysteine Topical magistral solution containing enrofloxacin	Prednisolone 0.5mg/kg q48h for 5 weeks No topicals treatments for one week
Case 2	Rottweiler	4.3	M	Unilateral SMO	1 year	Ear flush	Prednisolone 0.25 mg/kg q48h for 6 months Ketoconazole 10 mg/kg q24h for 6 weeks
Case 3	Labrador Retriever	10.5	FS	Bilateral SMO	5 years	Osurnia® and Surosolve^TM	None for 4 weeks
Case 4	Cross Breed	2.9	M	Bilateral: MO on the left ear and SMO on the right ear	2 years	Surolan® Easotic® Ear flush	Meloxicam oral No topical treatments for two weeks
Case 5	Labrador Retriever	4.9	M	Unilateral: MO	14 months	Marbodex® Marbofloxacin PO Surolan®	Ketoconazole 12 mg/kg PO q48h for several months No topical treatments for several months

Ingredients of medication: Aurizon® (Clotrimazole, Dexamethasone, Marbofloxacin), Acetylcysteine (Lysomucil 10%; Zambon S.A., Brussels, Belgium), Surosolve^TM (tromethamine-ethylenediaminetetraacetic acid (Tris-EDTA), chloroxylenol, salicylic acid); Marbodex® (marbofloxacin, clotrimazole, dexamethasone), Osurnia® (florfenicol, terbinafine and betamethasone.); Easotic® (hydrocortisone aceponate, miconazole and gentamicin); polymyxin, prednisolone and miconazole (Surolan®; Janssen Pharmaceutica NV, Beerse, Belgium)
Abbreviations: FS Female Spayed, MO Malassezia otitis, M Male, PO Per os SMO Suppurative Malassezia Otitis

ISSN: 1746-6148